Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITAPIVAT for Thalassaemia alpha: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where MITAPIVAT was used for Thalassaemia alpha.

Most Reported Side Effects for MITAPIVAT

Side Effect Reports % Deaths Hosp.
Haemoglobin decreased 161 25.7% 1 22
Fatigue 80 12.8% 0 7
Product dose omission issue 65 10.4% 0 14
Arthralgia 46 7.3% 0 0
Drug ineffective 44 7.0% 0 6
Off label use 44 7.0% 0 14
Headache 42 6.7% 0 3
Back pain 34 5.4% 0 3
Malaise 32 5.1% 1 3
Dyspnoea 30 4.8% 0 5
Asthenia 29 4.6% 0 4
Covid-19 26 4.2% 0 5
Product dose omission in error 26 4.2% 0 2
Pain 24 3.8% 1 1
Dizziness 21 3.4% 0 1

Other Indications for MITAPIVAT

Pyruvate kinase deficiency anaemia (499) Product used for unknown indication (56) Hereditary haemolytic anaemia (11) Haemolytic anaemia (7) Sickle cell disease (7) Thalassaemia beta (7) Anaemia of chronic disease (5)

Other Drugs Used for Thalassaemia alpha

DEFERIPRONE (26) DEFERASIROX (6)

Related Pages

MITAPIVAT Full Profile All Thalassaemia alpha Drugs MITAPIVAT Demographics MITAPIVAT Timeline